Q4 2024 Management View Chris Viehbacher, CEO, noted that Biogen is focused on three core priorities: driving growth from its four recently launched products, reprioritizing the pipeline for ...

CVS Health (NYSE:CVS), a leading integrated healthcare and pharmacy solutions provider, released its fourth-quarter 2024 ...

Gilead Sciences reported strong fourth-quarter earnings with significant growth in its HIV and oncology segments.

Ecolab Inc (NYSE:ECL) shares are trading higher after the company reported fourth-quarter sales growth of 2% year-on-year to ...

Reports Q4 revenue $3.2B, consensus $3.31B. “Ryder (R) delivered strong results in 2024 and year-over-year earnings growth during the fourth ...

Energy’s annual projection for 2025 earnings is between $4.67 per share and $4.82 per share. The Company also expects that its ...

The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

ConocoPhillips (NYSE:COP) shares are trading higher after the company released fourth-quarter results. Here’s a breakdown of ...

Investment analysts at Wedbush increased their FY2025 earnings per share (EPS) estimates for Electronic Arts in a research report issued to clients and investors on Wednesday, February 5th. Wedbush ...

Incyte says 2025 is expected to be a year of defining catalysts with four launches, four pivotal study readouts, at least ...

Snapchat (SNAP) reported its Q4 2024 earnings results today, posting beats on both earnings per share (EPS) and revenue ...

Arm Holdings published its Q3 2025 earnings results to its website at the close of markets today. The company tallied $983 ...